 | • レポートコード：MRC2-11QY00113 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脳マラリア治療薬のグローバル市場について調査・分析したレポートです。種類別（キニーネ、アルテミシニン誘導体）市場規模、用途別（小売薬局、オンライン薬局、病院薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脳マラリア治療薬の競争状況、市場シェア ・世界の脳マラリア治療薬市場：種類別市場規模 2015年-2020年（キニーネ、アルテミシニン誘導体） ・世界の脳マラリア治療薬市場：種類別市場規模予測 2021年-2026年（キニーネ、アルテミシニン誘導体） ・世界の脳マラリア治療薬市場：用途別市場規模 2015年-2020年（小売薬局、オンライン薬局、病院薬局、ドラッグストア） ・世界の脳マラリア治療薬市場：用途別市場規模予測 2021年-2026年（小売薬局、オンライン薬局、病院薬局、ドラッグストア） ・北米の脳マラリア治療薬市場分析：米国、カナダ ・ヨーロッパの脳マラリア治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脳マラリア治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脳マラリア治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脳マラリア治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Cipla、Zydus Cadila、Ipca Laboratories、Sanofi、Eisai ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
During cerebral malaria there is a state of unarousable coma with malaria infected blood in the peripheral circulation. The condition of coma is due to some other type of infections or hypoglycemia. The presence of retinopathy has been an addition in the clinical diagnosis of both adult and children. The postmortem studies done for observing the pathophysiology of cerebral malaria has found that Plasmodium falciparum infections accounts for majority of the cerebral malaria cases showing a common feature of vascular sequestration in the brain of infected erythrocytes. There is a difference between cerebral malaria in adults and in children. They can be differentiated based on the infected erythrocytes sequestration pattern with variable vascular pathology.
There has been a decline in the cases of malaria death and infections due to the research efforts. But at the same time, there has been an exponential rise in the drug resistance creating a need for new therapeutics. Moreover, the increase in the global temperature will expand the territory of mosquito-borne diseases driving a need to understand the molecular mechanism that underlines this parasitic infection.
Market Analysis and Insights: Global Cerebral Malaria Therapeutics Market
The global Cerebral Malaria Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cerebral Malaria Therapeutics Scope and Market Size
Cerebral Malaria Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cerebral Malaria Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cerebral Malaria Therapeutics market is segmented into
Quinine
Artemisinin Derivatives
Segment by Application, the Cerebral Malaria Therapeutics market is segmented into
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Drug Store
Regional and Country-level Analysis
The Cerebral Malaria Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cerebral Malaria Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cerebral Malaria Therapeutics Market Share Analysis
Cerebral Malaria Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cerebral Malaria Therapeutics business, the date to enter into the Cerebral Malaria Therapeutics market, Cerebral Malaria Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Novartis
Cipla
Zydus Cadila
Ipca Laboratories
Sanofi
Eisai
…
1 Study Coverage
1.1 Cerebral Malaria Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Cerebral Malaria Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cerebral Malaria Therapeutics Market Size Growth Rate by Type
1.4.2 Quinine
1.4.3 Artemisinin Derivatives
1.5 Market by Application
1.5.1 Global Cerebral Malaria Therapeutics Market Size Growth Rate by Application
1.5.2 Retail Pharmacies
1.5.3 Online Pharmacies
1.5.4 Hospital Pharmacies
1.5.5 Drug Store
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cerebral Malaria Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Cerebral Malaria Therapeutics Revenue 2015-2026
2.1.2 Global Cerebral Malaria Therapeutics Sales 2015-2026
2.2 Global Cerebral Malaria Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cerebral Malaria Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cerebral Malaria Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cerebral Malaria Therapeutics Competitor Landscape by Players
3.1 Cerebral Malaria Therapeutics Sales by Manufacturers
3.1.1 Cerebral Malaria Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Cerebral Malaria Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Cerebral Malaria Therapeutics Revenue by Manufacturers
3.2.1 Cerebral Malaria Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Cerebral Malaria Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cerebral Malaria Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cerebral Malaria Therapeutics Revenue in 2019
3.2.5 Global Cerebral Malaria Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cerebral Malaria Therapeutics Price by Manufacturers
3.4 Cerebral Malaria Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Cerebral Malaria Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cerebral Malaria Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Cerebral Malaria Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cerebral Malaria Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Cerebral Malaria Therapeutics Sales by Type (2015-2020)
4.1.2 Global Cerebral Malaria Therapeutics Revenue by Type (2015-2020)
4.1.3 Cerebral Malaria Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cerebral Malaria Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Cerebral Malaria Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Cerebral Malaria Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Cerebral Malaria Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cerebral Malaria Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cerebral Malaria Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Cerebral Malaria Therapeutics Sales by Application (2015-2020)
5.1.2 Global Cerebral Malaria Therapeutics Revenue by Application (2015-2020)
5.1.3 Cerebral Malaria Therapeutics Price by Application (2015-2020)
5.2 Cerebral Malaria Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Cerebral Malaria Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Cerebral Malaria Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Cerebral Malaria Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cerebral Malaria Therapeutics by Country
6.1.1 North America Cerebral Malaria Therapeutics Sales by Country
6.1.2 North America Cerebral Malaria Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cerebral Malaria Therapeutics Market Facts & Figures by Type
6.3 North America Cerebral Malaria Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Cerebral Malaria Therapeutics by Country
7.1.1 Europe Cerebral Malaria Therapeutics Sales by Country
7.1.2 Europe Cerebral Malaria Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cerebral Malaria Therapeutics Market Facts & Figures by Type
7.3 Europe Cerebral Malaria Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cerebral Malaria Therapeutics by Region
8.1.1 Asia Pacific Cerebral Malaria Therapeutics Sales by Region
8.1.2 Asia Pacific Cerebral Malaria Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cerebral Malaria Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Cerebral Malaria Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cerebral Malaria Therapeutics by Country
9.1.1 Latin America Cerebral Malaria Therapeutics Sales by Country
9.1.2 Latin America Cerebral Malaria Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cerebral Malaria Therapeutics Market Facts & Figures by Type
9.3 Central & South America Cerebral Malaria Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cerebral Malaria Therapeutics by Country
10.1.1 Middle East and Africa Cerebral Malaria Therapeutics Sales by Country
10.1.2 Middle East and Africa Cerebral Malaria Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cerebral Malaria Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Cerebral Malaria Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Cerebral Malaria Therapeutics Products Offered
11.1.5 Novartis Related Developments
11.2 Cipla
11.2.1 Cipla Corporation Information
11.2.2 Cipla Description and Business Overview
11.2.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cipla Cerebral Malaria Therapeutics Products Offered
11.2.5 Cipla Related Developments
11.3 Zydus Cadila
11.3.1 Zydus Cadila Corporation Information
11.3.2 Zydus Cadila Description and Business Overview
11.3.3 Zydus Cadila Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Zydus Cadila Cerebral Malaria Therapeutics Products Offered
11.3.5 Zydus Cadila Related Developments
11.4 Ipca Laboratories
11.4.1 Ipca Laboratories Corporation Information
11.4.2 Ipca Laboratories Description and Business Overview
11.4.3 Ipca Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ipca Laboratories Cerebral Malaria Therapeutics Products Offered
11.4.5 Ipca Laboratories Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Cerebral Malaria Therapeutics Products Offered
11.5.5 Sanofi Related Developments
11.6 Eisai
11.6.1 Eisai Corporation Information
11.6.2 Eisai Description and Business Overview
11.6.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eisai Cerebral Malaria Therapeutics Products Offered
11.6.5 Eisai Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Cerebral Malaria Therapeutics Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cerebral Malaria Therapeutics Market Estimates and Projections by Region
12.1.1 Global Cerebral Malaria Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Cerebral Malaria Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Cerebral Malaria Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Cerebral Malaria Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Cerebral Malaria Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Cerebral Malaria Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Cerebral Malaria Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Cerebral Malaria Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Cerebral Malaria Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Cerebral Malaria Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cerebral Malaria Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cerebral Malaria Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cerebral Malaria Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cerebral Malaria Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Cerebral Malaria Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Cerebral Malaria Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Cerebral Malaria Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Cerebral Malaria Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cerebral Malaria Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cerebral Malaria Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cerebral Malaria Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cerebral Malaria Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cerebral Malaria Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cerebral Malaria Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cerebral Malaria Therapeutics Market Segments
Table 2. Ranking of Global Top Cerebral Malaria Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cerebral Malaria Therapeutics Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Quinine
Table 5. Major Manufacturers of Artemisinin Derivatives
Table 6. Global Cerebral Malaria Therapeutics Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Cerebral Malaria Therapeutics Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Cerebral Malaria Therapeutics Sales by Regions 2015-2020 (K MT)
Table 9. Global Cerebral Malaria Therapeutics Sales Market Share by Regions (2015-2020)
Table 10. Global Cerebral Malaria Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Cerebral Malaria Therapeutics Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Cerebral Malaria Therapeutics Sales Share by Manufacturers (2015-2020)
Table 13. Global Cerebral Malaria Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Cerebral Malaria Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebral Malaria Therapeutics as of 2019)
Table 15. Cerebral Malaria Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Cerebral Malaria Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Cerebral Malaria Therapeutics Price (2015-2020) (USD/MT)
Table 18. Cerebral Malaria Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Cerebral Malaria Therapeutics Product Type
Table 20. Date of International Manufacturers Enter into Cerebral Malaria Therapeutics Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Cerebral Malaria Therapeutics Sales by Type (2015-2020) (K MT)
Table 23. Global Cerebral Malaria Therapeutics Sales Share by Type (2015-2020)
Table 24. Global Cerebral Malaria Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Cerebral Malaria Therapeutics Revenue Share by Type (2015-2020)
Table 26. Cerebral Malaria Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Cerebral Malaria Therapeutics Sales by Application (2015-2020) (K MT)
Table 28. Global Cerebral Malaria Therapeutics Sales Share by Application (2015-2020)
Table 29. North America Cerebral Malaria Therapeutics Sales by Country (2015-2020) (K MT)
Table 30. North America Cerebral Malaria Therapeutics Sales Market Share by Country (2015-2020)
Table 31. North America Cerebral Malaria Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Cerebral Malaria Therapeutics Revenue Market Share by Country (2015-2020)
Table 33. North America Cerebral Malaria Therapeutics Sales by Type (2015-2020) (K MT)
Table 34. North America Cerebral Malaria Therapeutics Sales Market Share by Type (2015-2020)
Table 35. North America Cerebral Malaria Therapeutics Sales by Application (2015-2020) (K MT)
Table 36. North America Cerebral Malaria Therapeutics Sales Market Share by Application (2015-2020)
Table 37. Europe Cerebral Malaria Therapeutics Sales by Country (2015-2020) (K MT)
Table 38. Europe Cerebral Malaria Therapeutics Sales Market Share by Country (2015-2020)
Table 39. Europe Cerebral Malaria Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Cerebral Malaria Therapeutics Revenue Market Share by Country (2015-2020)
Table 41. Europe Cerebral Malaria Therapeutics Sales by Type (2015-2020) (K MT)
Table 42. Europe Cerebral Malaria Therapeutics Sales Market Share by Type (2015-2020)
Table 43. Europe Cerebral Malaria Therapeutics Sales by Application (2015-2020) (K MT)
Table 44. Europe Cerebral Malaria Therapeutics Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Cerebral Malaria Therapeutics Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Cerebral Malaria Therapeutics Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Cerebral Malaria Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Cerebral Malaria Therapeutics Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Cerebral Malaria Therapeutics Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Cerebral Malaria Therapeutics Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Cerebral Malaria Therapeutics Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Cerebral Malaria Therapeutics Sales Market Share by Application (2015-2020)
Table 53. Latin America Cerebral Malaria Therapeutics Sales by Country (2015-2020) (K MT)
Table 54. Latin America Cerebral Malaria Therapeutics Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Cerebral Malaria Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Cerebral Malaria Therapeutics Revenue Market Share by Country (2015-2020)
Table 57. Latin America Cerebral Malaria Therapeutics Sales by Type (2015-2020) (K MT)
Table 58. Latin America Cerebral Malaria Therapeutics Sales Market Share by Type (2015-2020)
Table 59. Latin America Cerebral Malaria Therapeutics Sales by Application (2015-2020) (K MT)
Table 60. Latin America Cerebral Malaria Therapeutics Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Cerebral Malaria Therapeutics Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Cerebral Malaria Therapeutics Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Cerebral Malaria Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Cerebral Malaria Therapeutics Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Cerebral Malaria Therapeutics Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Cerebral Malaria Therapeutics Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Cerebral Malaria Therapeutics Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Cerebral Malaria Therapeutics Sales Market Share by Application (2015-2020)
Table 69. Novartis Corporation Information
Table 70. Novartis Description and Major Businesses
Table 71. Novartis Cerebral Malaria Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Novartis Product
Table 73. Novartis Recent Development
Table 74. Cipla Corporation Information
Table 75. Cipla Description and Major Businesses
Table 76. Cipla Cerebral Malaria Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Cipla Product
Table 78. Cipla Recent Development
Table 79. Zydus Cadila Corporation Information
Table 80. Zydus Cadila Description and Major Businesses
Table 81. Zydus Cadila Cerebral Malaria Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Zydus Cadila Product
Table 83. Zydus Cadila Recent Development
Table 84. Ipca Laboratories Corporation Information
Table 85. Ipca Laboratories Description and Major Businesses
Table 86. Ipca Laboratories Cerebral Malaria Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Ipca Laboratories Product
Table 88. Ipca Laboratories Recent Development
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Major Businesses
Table 91. Sanofi Cerebral Malaria Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Sanofi Product
Table 93. Sanofi Recent Development
Table 94. Eisai Corporation Information
Table 95. Eisai Description and Major Businesses
Table 96. Eisai Cerebral Malaria Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Eisai Product
Table 98. Eisai Recent Development
Table 99. Global Cerebral Malaria Therapeutics Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global Cerebral Malaria Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Cerebral Malaria Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Cerebral Malaria Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Cerebral Malaria Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: Cerebral Malaria Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Cerebral Malaria Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: Cerebral Malaria Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Cerebral Malaria Therapeutics Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: Cerebral Malaria Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Cerebral Malaria Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: Cerebral Malaria Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Cerebral Malaria Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: Cerebral Malaria Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Cerebral Malaria Therapeutics Players
Table 117. Cerebral Malaria Therapeutics Customers List
Table 118. Cerebral Malaria Therapeutics Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Cerebral Malaria Therapeutics Product Picture
Figure 2. Global Cerebral Malaria Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Quinine Product Picture
Figure 4. Artemisinin Derivatives Product Picture
Figure 5. Global Cerebral Malaria Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 6. Retail Pharmacies
Figure 7. Online Pharmacies
Figure 8. Hospital Pharmacies
Figure 9. Drug Store
Figure 10. Cerebral Malaria Therapeutics Report Years Considered
Figure 11. Global Cerebral Malaria Therapeutics Market Size 2015-2026 (US$ Million)
Figure 12. Global Cerebral Malaria Therapeutics Sales 2015-2026 (K MT)
Figure 13. Global Cerebral Malaria Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Cerebral Malaria Therapeutics Sales Market Share by Region (2015-2020)
Figure 15. Global Cerebral Malaria Therapeutics Sales Market Share by Region in 2019
Figure 16. Global Cerebral Malaria Therapeutics Revenue Market Share by Region (2015-2020)
Figure 17. Global Cerebral Malaria Therapeutics Revenue Market Share by Region in 2019
Figure 18. Global Cerebral Malaria Therapeutics Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Cerebral Malaria Therapeutics Revenue in 2019
Figure 20. Cerebral Malaria Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Cerebral Malaria Therapeutics Sales Market Share by Type (2015-2020)
Figure 22. Global Cerebral Malaria Therapeutics Sales Market Share by Type in 2019
Figure 23. Global Cerebral Malaria Therapeutics Revenue Market Share by Type (2015-2020)
Figure 24. Global Cerebral Malaria Therapeutics Revenue Market Share by Type in 2019
Figure 25. Global Cerebral Malaria Therapeutics Market Share by Price Range (2015-2020)
Figure 26. Global Cerebral Malaria Therapeutics Sales Market Share by Application (2015-2020)
Figure 27. Global Cerebral Malaria Therapeutics Sales Market Share by Application in 2019
Figure 28. Global Cerebral Malaria Therapeutics Revenue Market Share by Application (2015-2020)
Figure 29. Global Cerebral Malaria Therapeutics Revenue Market Share by Application in 2019
Figure 30. North America Cerebral Malaria Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Cerebral Malaria Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Cerebral Malaria Therapeutics Sales Market Share by Country in 2019
Figure 33. North America Cerebral Malaria Therapeutics Revenue Market Share by Country in 2019
Figure 34. U.S. Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Cerebral Malaria Therapeutics Market Share by Type in 2019
Figure 39. North America Cerebral Malaria Therapeutics Market Share by Application in 2019
Figure 40. Europe Cerebral Malaria Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Cerebral Malaria Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Cerebral Malaria Therapeutics Sales Market Share by Country in 2019
Figure 43. Europe Cerebral Malaria Therapeutics Revenue Market Share by Country in 2019
Figure 44. Germany Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Cerebral Malaria Therapeutics Market Share by Type in 2019
Figure 55. Europe Cerebral Malaria Therapeutics Market Share by Application in 2019
Figure 56. Asia Pacific Cerebral Malaria Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Cerebral Malaria Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Cerebral Malaria Therapeutics Sales Market Share by Region in 2019
Figure 59. Asia Pacific Cerebral Malaria Therapeutics Revenue Market Share by Region in 2019
Figure 60. China Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Cerebral Malaria Therapeutics Market Share by Type in 2019
Figure 83. Asia Pacific Cerebral Malaria Therapeutics Market Share by Application in 2019
Figure 84. Latin America Cerebral Malaria Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Cerebral Malaria Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Cerebral Malaria Therapeutics Sales Market Share by Country in 2019
Figure 87. Latin America Cerebral Malaria Therapeutics Revenue Market Share by Country in 2019
Figure 88. Mexico Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Cerebral Malaria Therapeutics Market Share by Type in 2019
Figure 95. Latin America Cerebral Malaria Therapeutics Market Share by Application in 2019
Figure 96. Middle East and Africa Cerebral Malaria Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Cerebral Malaria Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Cerebral Malaria Therapeutics Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Cerebral Malaria Therapeutics Revenue Market Share by Country in 2019
Figure 100. Turkey Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Cerebral Malaria Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Cerebral Malaria Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Cerebral Malaria Therapeutics Market Share by Type in 2019
Figure 107. Middle East and Africa Cerebral Malaria Therapeutics Market Share by Application in 2019
Figure 108. North America Cerebral Malaria Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Cerebral Malaria Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Cerebral Malaria Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Cerebral Malaria Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Cerebral Malaria Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Cerebral Malaria Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Cerebral Malaria Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Cerebral Malaria Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Cerebral Malaria Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Cerebral Malaria Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
虚血性脳卒中予防治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ischemic Cerebral Stroke Prevention Therapeutics Market The global Ischemic Cerebral Stroke Prevention Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ischemic Cerebral…- 脳脊髄液（CSF）管理の世界市場（～2026年） CSF is a clear, colorless body fluid found in the brain and spinal cord. CSF occupies the subarachnoid space (between the arachnoid mater and the pia mater) and the ventricular system around and inside the brain and spinal cord. Market Analysis and Insights: Global Cerebral Spinal Fluid (CSF) Manage…
- マラリア薬の世界市場（～2026年） Market Analysis and Insights: Global Malaria Drugs Market The global Malaria Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Malaria Drugs Scope and Market Size Malaria Drugs market is segmented by Type, and by A…
- 脳血管造影の世界市場（～2026年） Market Analysis and Insights: Global Cerebral Angiography Market The global Cerebral Angiography market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cerebral Angiography Scope and Market Size Cerebral Angiography market is…
- 閉経後骨粗鬆症治療薬の世界市場（～2026年） Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone. The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease. Market Analysis a…